Recursion Pharmaceuticals (RXRX) Divestments (2025)
Recursion Pharmaceuticals' (RXRX) quarterly Divestments came in at -$4.4 million in Q1 2025.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Divestments (2025) Analysis & Trends
Recursion Pharmaceuticals (RXRX) has 1 years of Divestments data on file, last reported at -$4.4 million in Q1 2025.
- Quarterly Divestments changed N/A year-over-year to -$4.4 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$4.4 million (changed N/A YoY) and the FY2025 annual result came in at -$4.4 million, changed N/A from the prior year.
- Divestments was little changed at -$4.4 million in Q1 2025.
- In the past five years, Divestments ranged from a high of -$4.4 million in Q1 2025 to a low of -$4.4 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.55 Bn | 58.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.32 Bn | 32.01 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.59 Bn | - | -13.21 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | Recursion Pharmaceuticals | 1.95 Bn | 1.40 Bn | -3.82 Mn | - |